Abstract：Objective To examine the interfractional dosimetric variations among inverse three-dimensional (3D) plan, forward 3D plan, and two-dimensional (2D) plan of intracavitary brachytherapy for cervical cancer, and to discuss the risk of implementing the interval plan on different implantation applicators at short time intervals. Methods Twenty-five groups of CT-guided intracavitary brachytherapy (two consecutive radiations at ≤4 d apart) plans from 11 cervical cancer patients who received radical radiation therapy in our hospital were reviewed and compared. The dwelling location and time of the first intracavitary brachytherapy plan (Plan-1) were simulated on the CT image of the second intracavitary brachytherapy to form Plan-1-S. The target coverage indices and D 2 cc of organs at risk (OARs) of Plan-1-S and Plan 2(actual plan of the second intracavitary brachytherapy) under the three planning modes were recorded and compared using the paired t-test, Wilcoxon signed rank test, and ANOVA. Results The D90, D100, and V100 of high-risk CTV were significantly lower in Plan-1-S created under the inverse mode in the actual plan (-9.11±13.46%,-13.16±18.79%, and -7.80±13.34%, P=0.002, 0.002, and 0.005, respectively). D90, D100, and V100 of the interval plan had the greatest reduction under the inverse mode (76%, 80%, and 76%, respectively). The maximum reductions in D90, D100, and V100 were 332.14 cGy (2D), 244.12 cGy (forward), and 41.76%(inverse). OAR overdose occurred most frequently under the forward mode;the rates of D90, D100, and V100 reductions accompanied by one OAR overdose were 29.41%, 37.50%, and 25.00%, and the rates of D90, D100, and V100 reductions by two OAR overdoses were 5.88%, 12.50%, and 6.25%,respectively. Overdose occurred most frequently in the small intestine (36%). Comparison of the three planning modes showed that the inverse plan had a greater reduction in each target coverage index than the 2D plan. Conclusions The simulated interval plan can significantly reduce target coverage and increase the risk of OAR overdose regardless of the planning mode and the short time intervals, and is therefore not recommended for clinical application.
Yan Junfang,Yu Lang,Hu Ke et al. Interfractional dosimetric study of target volume and organs at risk following intracavitary brachytherapy for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(9): 1045-1049.
[1] Han K, Milosevic M, Fyles A, et al. Trends in the utilization of brachytherapy in cervical cancer in the United States[J].Int J Radiat Oncol Biol Phys,2013,87(1):111-119.DOI:10.1016/j.ijrobp.2013.05.033. [2] Potter R,Georg P,Dimopoulos J.Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer[J].Radiother Oncol,2011,100(1):116-123.DOI:10.1016/j.radonc.2011.07.012. [3] Sturdza A,Potter R,Fokdal L,et al. Image guided brachytherapy in locally advanced cervical cancer:improved pelvic control and survival in retroEMBRACE,a multicenter cohort study[J].Radiother Oncol,2016,12(3):428-433.DOI:10.1016/j.radonc.2016.03.011. [4] Potter R,Dimopoulos J,Georg P,et al. Clinical impact of MRI assisted dose volume adaptation and escalation in brachyterapy of locally advanced cervix cancer[J].Radiother Oncol,2007,83(2):148-155.DOI:10.1016/j.radonc.2007.04.012. [5] Haie-Meder C,Potter R,Van Limbergen E,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO working group (I):concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV[J].Radiother Oncol,2005,74(3):235-245.DOI:10.1016/j.radonc.2004.12.015. [6] Kiristts C,Potter R,Lang S,et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer[J].Int J Radiat Oncol Biol Phys,2005,62(3):901-911.DOI:10.1016/j.ijrobp.205.02.040. [7] Johannes C,Dimopolos J,Lang S,et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy[J].Int J Radiat Oncol Biol Phys,2009,75(1):56-63.DOI:10.1016/j.ijrobp.2008.10.033 [8] Elhanafy OA,Das RK,Pailwal BR,et al. Anatomic variation of prescription points and treatment volume with fractionated high-dose rate gynecological brachytherapy[J].J Appl Clin Med Phys,2002,3(1):1-5.DOI:10.1120/1.1415202. [9] Jones ND,Rankin J,Gaffney DK.Is simulation necessary for each high-dose-rate tandem and ovoid insertion in carcinoma of the cervix?[J] Brachytherapy,2004,3(3):120-124.DOI:10.1016/j.brachy.2004.07.001. [10] Dolezel M,Odrazka K,Zizka,J,et al. MRI-based preplanning using CT and MRI data fusion in patients with cervical cancer treated with 3D-based brachytherapy:feasibility and accuracy study[J].Int J Radiat Oncol Biol Phys,2012.84(2):146-152. DOI:10.1016/j.ijrobp.2011.11.003 [11] 晏俊芳,于浪,孙玉亮,等.以CT图像为基础的宫颈癌三维腔内放疗[J].中华放射肿瘤学杂志,2014,23(5):377-381.DOI:10.3760/cma.j.issn.1004-4221.2014.05.002. Yan JF,Yu L,Sun YL,et al. A clinical study of CT image-based 3D brachytherapy for cervical cancer[J].Chin J Radiat Oncol, 2014,23(5):377-381.DOI:10.3760/cma.j.issn.1004-4221.2014.05.002. [12] Damato AL,Buzurovic L,Bhagwat MS,et al. The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy[J].Brachytherapy,2017,pii:S1538-4721(17)30014-4.DOI:10.1016/j.brachy.2017.01.008.
2017, Vol. 26 
